Connexin32 is a Myelin-Related Protein in the PNS and CNS by Scherer, Steven S. et al.
Sacred Heart University
DigitalCommons@SHU
Biology Faculty Publications Biology Department
12-1-1995
Connexin32 is a Myelin-Related Protein in the
PNS and CNS
Steven S. Scherer
University of Pennsylvania Medical Center
Suzanne M. Deschênes
Sacred Heart University, descheness@sacredheart.edu
Yi-Tian Xu
University of Pennsylvania Medical Center
Judith B. Grinspan
Kenneth H. Fischbeck
University of Pennsylvania Medical Center
See next page for additional authors
Follow this and additional works at: http://digitalcommons.sacredheart.edu/bio_fac
Part of the Cell Biology Commons, Genetics Commons, and the Laboratory and Basic Science
Research Commons
This Article is brought to you for free and open access by the Biology Department at DigitalCommons@SHU. It has been accepted for inclusion in
Biology Faculty Publications by an authorized administrator of DigitalCommons@SHU. For more information, please contact
ferribyp@sacredheart.edu.
Recommended Citation
Scherer, Steven S., Deschênes, Suzanne M., et. al. "Connexin32 is a Myelin-Related Protein in the PNS and CNS." The Journal of
Neuroscience 15.12 (1995): 8281-8294.
Authors
Steven S. Scherer, Suzanne M. Deschênes, Yi-Tian Xu, Judith B. Grinspan, Kenneth H. Fischbeck, and David
L. Paul
This article is available at DigitalCommons@SHU: http://digitalcommons.sacredheart.edu/bio_fac/44
The Journal of Neuroscience, December 1995, 75(12): 8281-8294 
Connexin32 Is a Myelin-Related Protein in the PNS and CNS 
Steven S. Scherer,’ Suzanne M. Desch&nes,’ Yi-tian Xu,’ Judith B. Grinspan,* Kenneth H. Fischbeck,’ and 
David L. Paul3 
1 Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6146, *Division of 
Neurological Research, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, and 3Department of 
Neurobiology, Harvard Medical School, Boston, Massachusetts 02115-6092 
We have examined the expression of a gap junction pro- 
tein, connexin32 (Cx32), in Schwann cells and oligodendro- 
cytes. In peripheral nerve, Cx32 is found in the paranodal 
myelin loops and Schmidt-Lanterman incisures of myeli- 
nating Schwann cells, and the levels of Cx32 protein and 
mRNA change in parallel with those of other myelin-related 
genes during development, Wallerian degeneration, and 
axonal regeneration. In the central nervous system, Cx32 
is found in oligodendrocytes and their processes, but not 
in compact myelin, and the levels of Cx32 protein and 
mRNA increase during development in parallel with those 
of the other myelin genes. Thus, Cx32 is expressed as part 
of the myelinating phenotype of both Schwann cells and 
oligodendrocytes, indicating that this gap junction protein 
plays in important role in the biology of myelin-forming 
cells. 
[Key words: Cx32, gap junctions, Schwann cells, oligo- 
dendrocytes, myelin, incisures] 
Myelin is the multi-lamellar structure that surrounds axons and 
increases axonal conduction velocity. It is formed by the spiral 
wrapping of the cell membrane of myelinating glia-oligodendro- 
cytes in the CNS and Schwann cells in the PNS. The myelin 
sheaths produced by these two cell types are structurally similar, 
consisting mostly of compact myelin that is characterized by a 
unique but overlapping set of ,proteins (Lemke, 1992, 1993). 
Proteolipid protein (PLP) and myelin basic protein (MBP) are 
the major structural proteins in the CNS, while protein zero (PO), 
MBP and peripheral myelin protein-22 kD (PMP-22) are the 
major proteins in the PNS. Each of these myelin proteins is 
essential for proper myelination, as mutations in PLP and MBP 
cause dysmyelination in the CNS, and mutations in P, and PMP- 
22 cause dysmyelination in the PNS (Hudson, 1990; Chance and 
Pleasure, 1993; Lemke, 1993; Snipes and Suter, 1995). 
The compact myelin in the PNS contains periodic interrup- 
tions called Schmidt-Lanterman incisures or clefts (Peters et al., 
1991). These incisures, as well as the paranodal regions of the 
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myelin sheath, contain a distinct group of proteins, including 
myelin-associated glycoprotein (MAG), connexin32 (Cx32), 
E-cadherin, and oligodendrocyte-myelin glycoprotein (Trapp et 
al., 1989; Bergoffen et al., 1993; Apostolski et al., 1994; Fannon 
et al., 1995). Incisures have also been reported in the CNS (Pe- 
ters et al., 1991), but no molecules have yet been found to be 
preferentially localized to CNS incisures. The importance of the 
incisures to the normal function of myelinated axons was not 
appreciated until it was found that the X-linked form of Charcot- 
Marie-Tooth disease (CMTX) was caused by mutations in the 
Cx32 gene (Bergoffen et al., 1993). Cx32 is a gap junction pro- 
tein and is expressed in many tissues, including oligodendro- 
cytes and myelinating Schwann cells (Kumar and Gilula, 1986; 
Paul, 1986; Dermietzel et al., 1989, 1990; Bennett et al., 1991; 
Kumar and Gilula, 1992; Bergoffen et al., 1993). How Cx32 
mutations cause peripheral neuropathy is unknown. One plau- 
sible explanation is that CMTX mutations alter the function of 
gap junctions at nodes and incisures, as Cx32-immunoreactivity 
colocalizes with gap junctions seen by freeze-fracture electron 
microscopy (Sandri et al., 1982; Bergoffen et al., 1993), and 
some mutations in Cx32 disrupt the formation of functional gap 
junctions (Bruzzone et al., 1994; Rabadan-Diehl et al., 1994). If 
CMTX mutations disrupted these gap junctions, this could in- 
terrupt the diffusion of ions and small molecules in a radial 
direction, directly across the myelin sheath, through the para- 
nodes and incisures. 
To learn more about the role of Cx32 in myelinating glia, we 
examined the localization and expression of Cx32 in Schwann 
cells and oligodendrocytes. In the PNS, Cx32 is found in the 
paranodal regions and incisures of myelinating Schwann cells. 
In the CNS, Cx32 is found in cell bodies and processes of oli- 
godendrocytes, but not in compact myelin or Schmidt-Lanter- 
man incisures. Axon-Schwann cell interactions in vivo, and 
CAMP analogs in vitro, increase Cx32 expression in Schwann 
cells. In the CNS, the level of Cx32 mRNA increases in different 
regions in parallel with those of the other myelin genes. Fur- 
thermore, in jimpy mice and rnyelin-deficient rats, which have 
PLP mutations that result in the failure of oligodendrocyte mat- 
uration (Hudson, 1990), the level of Cx32 mRNA, like those of 
other myelin-related genes, does not increase during the period 
of myelination. Thus, Cx32 is expressed as part of the program 
of myelin gene expression in both oligodendrocytes and 
Schwann cells, but is localized to different parts of each cell. 
Materials and Methods 
Surgery and collection of tissues. Using aseptic technique, the sciatic 
nerves of anesthetized (50 mg/kg pentobarbital i.p.), adult (lo-13 week 
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old) Sprague-Dawley rats were exposed at the sciatic notch. Permanent 
axotomy was accomplished by doubly ligating nerves, transecting be- 
tween the ligatures with iridectomy scissors, and suturing the two nerve- 
stumps were at least 1 cm apart; this technique prevents axonal regen- 
eration to the distal nerve-stump for at least 2 months. Nerve-crush was 
produced by tightly compressing the sciatic nerve at the sciatic notch 
with flattened forceps twice, each time for 10 set; this technique causes 
all of the axons to degenerate, but allows axonal regeneration. At var- 
ious times after nerve-injury, the animals were sacrificed by CO, in- 
halation, the distal nerve-stumps were removed, and the most proximal 
2-3 mm were trimmed off. For transected nerves, the entire distal 
nerve-stump was taken from just below the lesion to the ankle (about 
4 cm). For crushed nerves, the distal nerve-stump was divided into two 
equal segments, termed the proximal and distal segments, each about 2 
cm long. The nerves were immediately frozen in liquid nitrogen and 
stored at -80°C. Unlesioned sciatic nerves and various brain regions 
were obtained from animals of different ages, from Pl (the day after 
birth) to P90. All animal protocols were approved by the Institutional 
Animal Care and Use Committee of The University of Pennsylvania. 
Cell culture. Schwann cells were isolated from 3 d old rat pups 
(Brockes et al., 1979), and expanded on 10 cm plates coated with poly- 
L-lysine in DME supplemented with 10% FCS, a crude extract of glial 
growth factor (Brockes et al., 1980), and 2 FM forskolin (Porter et al., 
1986). The cells were passaged three times, grown to confluence, then 
switched for 3 d to either DMEM + 10% FCS, or DMEM + 10% FCS 
supplemented with 4 FM forskolin. All of the cultures used in these 
experiments were >95% Schwann cells, as judged by staining for the 
low-affinity nerve growth factor receptor (NGFR; data not shown). Fi- 
broblasts were obtained by culturing the perineurium in DMEM + 10% 
FCS on uncoated plastic plates, to which Schwann cells did not adhere. 
RNA and protein were isolated after the cells had been passaged three 
times. 
Immunohistochemistry and immunocytochemistry. Nerve fibers were 
teased from fresh, unfixed nerves, or from nerves that had been fixed 
for 30 min in 4% paraformaldehyde or Zamboni’s fixative. Teased fibers 
were dried on glass slides, then postfixed for 10 min with acetone. The 
best Cx32 labeling was obtained from tissues that were embedded in 
OCT (Miles, Elkhart. IN). without urior fixation or after fixation in 4% 
paraformaldehyde. Frozen sections bf unfixed tissue were posttixed for 
10 min in acetone. Teased fibers and sections were blocked for at least 
1 hr in 10% fish skin gelatin containing 0.5% Triton X, and incubated 
24-48 hr at 4°C with various combinations of primary antibodies. We 
used mouse monoclonal antibodies against rat Cx32 (M12.13, (Good- 
enough et al., 1988), P, (Archelos et al., 1993), MAC (Boehringer- 
Mannheim, Indianapolis, IN), myelin-oligodendrocyte glycoproiein 
(MOG; Linnington et al., 1984). growth-associated orotein-43 kD 
(GAP-43; Schreyer and Skene, 1991): and rabbit polyclonal antibodies 
against rat Cx32 (Goodenough et al., 1988), MAG (Pedraza et al., 
1990), PLP (Koeppen et al., 1988), P, (D’Urso et al., 1990), nestin 
(Friedman et al., 1990), GAP-43 (Curtis et al., 1992), and ED 1 (Serotec; 
England). After incubating with the primary antibodies, the sections 
were washed, then incubated with the appropriate fluorescein-, rhoda- 
mine-, or biotin-conjugated donkey anti-rabbit and anti-mouse second- 
ary antibodies (Jackson ImmunoResearch Laboratories, West Grove, 
PA). Fluorescein- or rhodamine-conjugated avidin was used to visualize 
biotin-conjugated antibodies. 
The rabbit antiserum against Cx32 was an unfractionated serum gen- 
erated against a synthetic peptide corresponding to amino acids 98-l 24 
of Cx32 (Paul, 1986; Goodenough et al., 1988). This antibody recog- 
nizes Cx32 on Western blots and labels gap junctions by immunoelec- 
tron microscopy (Paul, 1986; Goodenough et al., 1988). Preincubation 
of the antiserum with the peptide against which it was raised abolishes 
Cx32 staining in several tissues (D. Paul, unpublished observations). 
The monoclonal antibody against rat Cx32 (M12.13) probably recog- 
nizes an epitope in the C-terminal cytoplasmic domain (Goodenough et 
al., 1988). In peripheral nerve and spinal cord both the polyclonal and 
the monoclonal antibodies gave identical patterns of staining. Further- 
more, the preimmune rabbit serum, diluted to have the same protein 
concentration as the antiserum itself, did not label either peripheral 
nerve or spinal cord. 
Western blotting. Protein homogenates were obtained by pulverizing 
frozen tissues with a steel mortar and pestle on dry ice, homogenized 
in 50 mu Tris (pH 7.0) containing 1% SDS and 100 FM PMSE then 
sonicated. Protein extracts were similarly prepared from cultured 
Schwann cells after scraping the cells into the same solution. A myelin 
preparation was isolated from cerebrum, brainstem, and spinal cord of 
adult rats (Norton and Poduslo, 1973) lyophilized, and resuspended in 
the same solution. Insoluble material was removed by centrifugation in 
a microfuge for 15 min at 15,000 rpm, and the concentration of protein 
in the supernatant was measured with a Bio-Rad DC Assay kit accord- 
ing to the manufacturer’s instructions. Equal amounts (25 p,g) of protein 
were separated on 12% acrylamide, 0.1% SDS gels, transferred to Im- 
mobilon PVDF membrane- (NEN Research Systems, Boston, MA), 
blocked (5% oowdered milk in TRIS-buffered saline containing 0.5% 
Tween20) overnight at 4”C, then incubated with a rabbit anzserum 
against rat Cx32 (Goodenough et al., 1988), diluted 1:5000, for 24 hr 
at 4°C. The membranes were washed in blocking solution, then incu- 
bated at room temperature in peroxidase-coupled donkey anti-rabbit im- 
munoglobulin (Jackson ImmunoResearch Laboratory, West Grove, PA), 
diluted 1: 10,000. After 1 hr, the membranes were washed, developed 
with chemiluminescence reagent (ECL kit, Amersham, Arlington 
Heights, IL), and exposed to film (Kodak X-OMAT AR imaging film). 
The membranes were reprobed with a rabbit antiserum against a peptide 
encoded by exon 1 of human MBP (diluted 1:5000; DeFerra et al., 
1985), a rabbit antiserum against P,, (diluted 1:5000; D’Urso et al., 
1990), or a rabbit antiserum against PLP (diluted 1:2000; Koeppen et 
al., 1988). To show the specificity of the primary antibodies, duplicate 
membranes were similarly prepared, but the primary antibody was omit- 
ted. 
Northern blotting. RNA was isolated from rat sciatic nerves and 
Schwann cells by CsCl, gradient centrifugation (Chirgwin et al., 1979). 
Equal amounts (10 pg) of total RNA were electrophoresed in I % aga- 
rose, 2.2 M formaldehyde gels, transferred to nylon membranes (Dura- 
lon, Stratagene) in 6X SSC, and U.V. cross-linked (0.12 joules). Blots 
were prehybridized, hybridized, and washed using standard techniques; 
the final stringency of the wash was 0.2X SSC at 65°C for 30 min 
(Sambrook et al., 1989). The following cDNAs were used as probes- 
a 1.1 kb fragment of rat Cx32 (Paul, 1986), a full-length cDNA of rat 
P,, (Lemke and Axel, 1985), a 0.7 kb BamHI fragment of rat NGFR 
(Radeke et al., 1987), and a full-length cDNA of rat glyceraldehyde 
3-phosphate dehydrogenase (GAPDH; (Fort et al., 1985). Plasmid in- 
serts were isolated after restriction endonuclease digestion by agarose 
gel electrophoresis, and purified by electroelution. ?2P-Labeled cDNA 
probes with specific activities of 2-5 X lo” cpm/kg were prepared by 
primer extension with random hexamers using the Prim-a-gene kit (Pro- 
mega) according to the manufacturer’s instructions. 
Results 
Cx32 is expressed by myelinating Schwann cells 
In our initial report, we found that Cx32 appeared to be localized 
to the paranodes and Schmidt-Lanterman incisures of PNS my- 
elin (Bergoffen et al., 1993). We have confirmed and extended 
this observation by double-labeling cryosections and teased fi- 
bers for Cx32 and MAG, pairing a mouse monoclonal antibody 
against Cx32 with a rabbit polyclonal antibody against MAG, 
and a rabbit polyclonal antibody against Cx32 with a mouse 
monoclonal antibody against MAG. Both combinations of anti- 
bodies gave similar results. In agreement’with previous reports 
(Sternberger et al., 1979; Trapp and Quarles, 1982, 1984; Trapp 
et al., 1984), Figure 1B demonstrates that MAG-immunoreactiv- 
ity was found around the entire aGaxona1 surface of myelinating 
Schwann cells (arrowheads), which apposes the axon, and in the 
incisures (arrows) and paranodes (not shown). Figure IA dem- 
onstrates that Cx32-immunoreactivity colocalized with MAG at 
the incisures. At the adaxonal Schwann cell membrane, however, 
there was only a thin line of Cx32 staining, which probably 
corresponded to the inner mesaxon (Peters et al., 199 1). We also 
performed double-labeling for Cx32 and P,, (Fig. 2). P,, was 
found throughout the compact myelin (Fig. 2B; Trapp et al., 
1981), whereas Cx32 staining (Fig. 2A) was chiefly found at 
incisures (arrows) and paranodes (arrowheads). Thus, the local- 
ization of Cx32 in mature myelinated axons matches the local- 
ization of gap junctions in the PNS myelin sheath by freeze- 
fracture-at the paranodes, incisures, and inner mesaxon (Sandri 
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Figure I. Immunohistochemical analysis of Cx32 and MAG in adult 
sciatic nerve. These are photomicrographs of a teased fiber that was 
labelled with a combination of a mouse monoclonal antibody against 
rat Cx32 (A) and a rabbit antiserum against MAG (B) and visualized 
with fluorescein- and rhodamine-coupled secondary antibodies, respec- 
tively. Cx32- and MAG-immunoreactivity colocalize at incisures (ar- 
rows), which are conical structures that traverse the unstained compact 
et al., 1982). In addition, we also noted perinuclear Cx32 stain- 
ing (data not shown), as has been noted for other components 
of the myelin sheath (Trapp et al., 1981). 
To determine whether Cx32 is expressed in nonmyelinating 
Schwann cells, we examined teased fibers in the cervical sym- 
pathetic trunk, which is composed of unmyelinated axons, their 
associated (nonmyelinating) Schwann cells, as well as a few, 
thinly myelinated axons (Aguayo et al., 1976). As shown in 
Figure 3, A and B, there was an identical pattern of adaxonal 
Cx32- and MAG-immunoreactivity, respectively, in myelinating 
Schwann cells (arrows). Thus, Cx32-immunoreactivity was not 
confined to the inner mesaxon of these small myelinated fibers, 
but appeared to surround their entire adaxonal circumference. 
These small myelinated axons had internodal lengths of only 
50-70 p,m, and typically lacked incisures, like the fibers shown 
in Figure 3. When incisures were present, they were Cx32- and 
MAG-positive (data not shown). Nonmyelinating Schwann cells 
also had Cx32-immunoreactivity, although this staining was 
punctate and discontinuous, and overall significantly less than 
that seen in myelinating Schwann cells (Fig. 3A). We confirmed 
that these were nonmyelinating Schwann cells by double-label- 
ing for both Cx32 and GAP-43, as GAP-43 labels unmyelinated 
axons and their associated nonmyelinating Schwann cells (data 
not shown; see Curtis et al., 1992). 
To examine the onset of Cx32 expression during development, 
we examined teased fibers and sections of postnatal day 6 (P6) 
sciatic nerves. At this age, the sciatic nerve contains axons at 
many stages of ensheathment, including axons that have just 
begun to be myelinated (Webster and Favilla, 1984). There were 
many myelin sheaths in P6 nerves, and some had incisures that 
were MAG-positive, but there was little, if any, detectable Cx32 
staining of incisures. The Cx32 staining that was present ap- 
peared to be associated with the inner mesaxon (data not shown). 
Thus, the onset of Cx32 expression in the incisures and para- 
nodes may lag that of MAG. 
Axotomy disrupts axon-Schwann cell interactions, causing 
the degeneration of the axons and their myelin sheaths, and a 
dramatic reduction in the expression of myelin-related proteins 
(Mirsky and Jessen, 1990; Scherer and Asbury, 1993). We ex- 
amined Cx32 expression in nerves that were transected to cause 
permanent axotomy, as well as nerves were focally crushed, to 
cause Wallerian degeneration but promote axonal regeneration. 
In permanently transected nerves, Cx32 disappeared from mye- 
linating Schwann cells in parallel with the loss of MAG (data 
not shown). The Schwann cells themselves, however, persisted, 
and could be labelled with an antibody against nestin (Fig. 4). 
At 58 d posttransection, Cx32-, MAG-, P,-, and MBP-immu- 
noreactivity were found macrophages (St011 et al., 1989), which 
were EDl-positive and nestin-negative (Fig. 4). In crushed 
nerves, Cx32-immunoreactivity was found in incisures and par- 
anodal regions of remyelinated fibers by 24 d postlesion (data 
not shown). These data demonstrate that the expression of Cx32 
protein is linked to the formation of the myelin sheath in 
Schwann cells. 
To confirm that peripheral nerve contains Cx32, and to sub- 
stantiate the changes in Cx32 protein expression after nerve- 
+- 
myelin sheath. MAG also surrounds the axon at the adaxonal Schwann 
cell surface (between arrowheads in B), whereas only a thin line of 
Cx32 staining is found at the adaxonal surface, probably at the inner 
mesaxon (arrows in A). Scale bar, 10 pm. 
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Figure 2. Immunohistochemical localization of Cx32 and PO in adult sciatic nerve. These are photomicrographs of teased fibers, double-labs 
with a monoclonal antibody against rat Cx32 (A.C) and a rabbit polyclonal antibody against rat P, (B) and visualized with fluorescein- 
rhodamine-coupled secondary antibodies, respectively. Note that Cx32 is predominantly found at the incisures (some of which are indicated 
arrows in A) and paranodes (arrowheads in A and B), whereas the P,, is found throughout the compact myelin sheath. C is an enlargement of 
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Figure 3. Immunohistochemical localization of Cx32 and MAG in 
adult cervical sympathetic trunk. These are photomicrographs of a bun- 
dle of teased fibers, double-labeled with a monoclonal antibody against 
rat Cx32 (A) and a rabbit polyclonal antibody against rat MAG (B) and 
visualized with fluorescein- and rhodamine-coupled secondary antibod- 
ies, respectively. There is a single myelinated fiber in this field, with 
two internodes (the arrows indicate the positions of the two Schwann 
cell nuclei), separated by nodes (arrowheads). The pattern of Cx32 and 
MAG staining of the two myelinating Schwann cells is essentially iden- 
tical; neither one appears to have an incisure and the immunoreactivity 
is not restricted to the paranodes. Note that many nonmyelinating 
Schwann cells have some Cx32 staining, but little MAG staining. Scale 
bar, 10 pm. 
injury, we performed Western blot analysis using a rabbit anti- 
body against rat Cx32. As shown in Figure 5A, in unlesioned 
nerves (the lanes labeled “O”), this antibody recognized a pro- 
tein of approximately 32 kDa molecular mass (arrowhead), as 
well as a dimer of Cx32 (double arrowhead), which results from 
the incomplete solubilization of Cx32 in SDS (Paul, 1986). The 
amount of Cx32 fell between 1 and 12 d posttransection, and 
did not increase thereafter. Prolonged exposure of the blot, how- 
ever, demonstrated detectable Cx32 even at 60 d (data not 
shown). In crushed nerves, the amount of Cx32 fell between 1 
and 12 d, as in transected nerves, but returned to near normal 
levels by 60 d post-crush. Reprobing the blots for P, demon- 
strated that the amount of this myelin protein also fell progres- 
sively in permanently transected nerves, and returned to normal 
in crushed nerves at 60 d (Fig. 5B). These data demonstrate that 
Cx32 is found in peripheral nerve, and that the amount of Cx32 
Figure 4. Immunohistochemical localization of Cx32 in permanently 
axotomized adult sciatic nerve. These are photomicrographs of the same 
field of a longitudinal section of nerve 58 d post transection, double- 
labeled for Cx32 (rhodamine, A) and (nestin; fluorescein, B). The arrows 
indicate three macrophages that have Cx32-immunoreactivity (A) but 
are nestin-negative (B). The nestin-positive structures are Schwann cell 
processes. Scale bar, 10 brn. 
protein, like many myelin proteins, depends on the maintenance 
of axonal interactions (Mirsky and Jessen, 1990; Scherer and 
Asbury, 1993). 
Cx32 mRNA is expressed in concert with other myelin-related 
genes and is regulated by axon-Schwann cell interactions and 
forskolin 
Since the mRNAs of the major myelin genes accumulate in par- 
allel during the development of the PNS (Stahl et al., 1990; 
Snipes et al., 1992), we examined the expression of Cx32 
mRNA by Northern blot analysis. In the sciatic nerve, the level 
of PO mRNA increased dramatically after birth (Fig. 6). Reprob- 
ing the blot for Cx32 mRNA demonstrated that Cx32 mRNA 
changed during development in an identical pattern (the band 
indicated by the arrowhead in Fig. 6A), which is consistent with 
the idea that myelinating Schwann cells express Cx32 mRNA. 
Since the maintenance of the myelinating phenotype, includ- 
ing the expression of high levels of myelin-related mRNAs, de- 
pends on the integrity of axon-Schwann cell interactions (Mir- 
sky and Jessen, 1990; Scherer and Asbury, 1993), we examined 




Figure 5. Western blot analysis of lesioned adult rat sciatic nerves. Each lane contains an equal amount (25 pg) of protein homogenate from the 
distal nerve-stumps of sciatic nerves 1, 4, 8, 12, 28, or 60 d posttransection or crush; the “0” time point is from unlesioned nerves. The blots were 
hybridized together with a rabbit antiserum against rat Cx32, and then rehybridized with a rabbit antiserum against rat P,. The blots were exposed 
to film for 30 min (Cx32) or 1 set (PO). The arrow marks the position of the Cx32 monomer, and the double arrowhead marks the position of the 
Cx32 dimer (Paul, 1986). 
the expression of Cx32 mRNA after permanent axotomy and 
nerve-crush. The distal nerve-stumps of crushed nerves were 
divided into a proximal and a distal segment, to facilitate the 
analysis of how changes in Schwann cell gene expression de- 
pend on regenerating axons, as axons regenerate in a proximal 
to distal manner. In permanently transected nerves, the level of 
Cx32 mRNA fell sharply between 1 and 8 d postlesion and did 
not return even by 58 d (Fig. 7). In crushed nerves, the level of 
Cx32 mRNA also fell between 1 and 8 d postlesion, but then 
increased. This increase was first seen in the proximal segment 
of the distal nerve-stump at 12 d, and in the distal segment at 
24 d. Reprobing the blots demonstrated that the level of P, 
mRNA in transected and crushed nerves followed essentially the 
same pattern as that of Cx32, except that the level of P0 mRNA 
fell more promptly than that of Cx32 (Fig. 7). Reprobing the 
blots for the low-affinity nerve growth factor receptor (NGFR) 
mRNA demonstrated a reciprocal pattern to that of Cx32 and 
P,, consistent with the evidence that myelinating Schwann cells 
do not express NGFR, whereas “denervated” Schwann cells 
express NGFR and not myelin-related genes (Mirsky and Jessen, 




CAMP analogs mimick some of the effects of axon-Schwann 
cell interactions, such as increasing the expression of galacto- 
cerebroside, sulfatide, and P,, and inhibiting the expression of 
NGFR and GAP-43 (Sobue and Pleasure, 1984; Lemke and 
Chao, 1988; Morgan et al., 1991, 1994; Scherer et al., 1994). 
To determine whether CAMP would increase the level of Cx32 
mRNA, we performed Northern blot analysis of cultured rat 
Schwann cells treated for 3 d with 4 p,M forskolin, an activator 
of adenylate cyclase (Seamon et al., 1981). As shown in Figure 
8, forskolin increased the levels of Cx32 and P, mRNA, but the 
level was not as high as in unlesioned sciatic nerve. Cultured 
perineurial fibroblasts, which are the other major cell type in 
peripheral nerve and coupled by gap junctions (Reale et al., 
1975; Schiavinato et al., 1991), did not express Cx32 mRNA 
Figure 6. Northern blot analysis of developing sciatic nerve. Each 
lane contains an equal amount (10 pg) of total RNA isolated from the 
distal stumps of sciatic nerves of various ages. The blots were succes- 
sively hybridized with a radiolabeled cDNA-probe for P,, (B), Cx32 (A), 
and GAPDH (C), and exposed to film for 3 hr (P,), 14 d (Cx32), and 
1 d (GAPDH), respectively. The arrowhead marks the Cx32 mRNA; 
the double arrowhead indicates the signal from the previous hybridiza- 









Figure 7. Northern blot analysis of normal and lesioned adult rat sciatic nerves. Each lane contains an equal amount (10 bg) of total RNA isolated 
from the distal stumps of sciatic nerves that had been transected or crushed. The number of days after each of these lesions in indicated; the “0” 
time point is from unlesioned nerves. In crushed nerves, the distal nerve-stumps were divided into proximal (P) and distal (D) segments of equal 
lengths. The blots were successively hybridized with a radiolabeled cDNA probe for Cx32 (A), P, (B), NGFR (C), and GAPDH (D), and exposed 
to film for 14 d (Cx32), 2 hr (P,), 1 d (NGFR), and 3 d (GAPDH), respectively. 
even when treated with forskolin, but did express Cx43 mRNA 
(Fig. 8). To determine whether forskolin increased the expres- 
sion of Cx32 protein, we prepared Western blots of Schwann 
cells that had been treated for 3 d with 0, 4, or 20 pM forskolin. 
We did not detect Cx32 in either untreated or treated Schwann 
cells, whereas reprobing the blot for P, demonstrated a robust 
increase in P, protein in forskolin-treated cells (data not shown). 
Thus, forskolin increases the expression of Cx32 mRNA in a 
similar manner to other myelin-related genes. 
Connexin32 is expressed by oligodendrocytes 
Although Cx32 has been reported to be expressed by oligoden- 
drocytes and neurons (Dermietzel et al., 1989; Micevych and 
Abelson, 1991; Yamamoto et al., 1991; Robinson et al., 1993), 
the clinical data indicate that CMTX patients do not usually have 
CNS abnormalities (Phillips et al., 1985; Rozear et al., 1987; 
Hahn et al., 1990; Ionasescu et al., 1992). Hence, even though 
Schwann cells and oligodendrocytes both express Cx32 and are 
the sole myelin-forming cells, oligodendrocytes may not be af- 
fected by mutations of Cx32. 
We examined the expression of Cx32 in the developing rat 
spinal cord, which contains a number of tracts that myelinate at 
different times in postnatal development (Schwab and Schnell, 
1989; Baron et al., 1993). At Pl, Cx32 colocalized with MAG 
and PLP in the cell bodies of developing oligodendrocytes (data 
not shown). In adult spinal cord, the most prominent Cx32-im- 
munoreactivity was found in the cell bodies and processes of 
oligodendrocytes, but the myelin sheaths themselves were not 
stained (Fig. 9A,C). To confirm and extend these findings, we 
double-labeled sections for Cx32 and MAG and for Cx32 and 
myelin-oligodendrocyte glycoprotein (MOG), as MAG and 
MOG are localized to the adaxonal and abaxonal surfaces of the 
myelin sheath, respectively (Sternberger et al., 1979; Brunner et 
al., 1989). Cx32 colocalized with MAG in oligodendrocyte cell 
bodies, but Cx32 labeling did not colocalize with that of MAG 
at the adaxonal surface of oligodendrocytes (data not shown). 
Cx32 colocalized with MOG in some oligodendrocyte processes, 
but the adaxonal surface of the myelin sheath was mostly Cx32- 
negative (Fig. 9). Thus, while Cx32 is a myelin-related protein 
in the PNS and CNS, it is distributed in different aspects of the 
myelinating cell. 
The localization of Cx32 in the spinal cord suggested that it 
predominately expressed by oligodendrocytes. Since the onset 
and tempo of myelination in the CNS differ in the various my- 
elinated fiber tracts of the CNS (Jacobson, 1963; Cohen and 
Guarnieri, 1976), we examined the accumulation of Cx32 pro- 












Figure 8. Northern blot analysis of cultured Schwann cells and fibro- 
blasts. Each lane contains an equal amount (30 kg) of total RNA iso- 
lated from Schwann cells or fibroblasts cultured for 3 d in the absence 
(lane 0) or presence of 4 pM forskolin. For comparison, a sample of 
normal sciatic nerve RNA was run in an adjacent lane (marked SN). 
The blot was successively hybridized with a radiolabeled cDNA probe 
for Cx32 (A), P, (B), GAPDH (D), and Cx43 (C), and exposed to film 
for 12 d (Cx32), 2 hr (P,), 4 d (Cx43), and 3 d (GAPDH). 
tein in different CNS regions by Western blot analysis. Protein 
homogenates of spinal cord, brainstem, cerebellum, and cere- 
brum were prepared from rats of various ages, from Pl to P90. 
The blots were probed with a rabbit antiserum against Cx32, 
then the same blots were reprobed with a rabbit antiserum 
against PLP Cx32 and PLP were more abundant in the brainstem 
and spinal cord (Fig. 10) than in the cerebrum and cerebellum 
(not shown), and the amount of Cx32 and PLP in each brain 
region increased from Pl to P90 (Fig. 10). We also made a 
myelin preparation of adult cerebrum, brainstem, and spinal 
cord, to enrich for membrane-related proteins, in order to com- 
pare the amount of Cx32 in the myelin fractions to that in ho- 
mogenates of the corresponding brain regions. Western blot 
analysis demonstrated that in each brain region, the myelin frac- 
tion contained relatively more Cx32, and that PLP was enriched 
to a similar extent (Fig. 10). These results demonstrate that Cx32 
accumulates in parallel with other myelin proteins during de- 
velopment. 
Cx32 mRNA is expressed in concert with other myelin-related 
genes in oligodendrocytes 
Like the myelin proteins, the myelin-related mRNAs accumulate 
in parallel during the development of the CNS, with modest 
differences between different brain regions (Kanfer et al., 1989; 
Scherer et al., 1994). Thus, we compared the expression of Cx32 
mRNA in the cerebrum, cerebellum, and brainstem to that of 
PLP (Fig. 11). In each region, the levels of Cx32 and PLP 
mRNA were parallel, with a similar onset and peak. Prolonged 
overexposure of the blot demonstrated, however, a low level of 
Cx32 mRNA expression prior to the onset of PLP mRNA ex- 
pression (data not shown), consistent with the idea that neurons 
express Cx32 prior to oligodendrocytes. 
The above findings indicate that most of the Cx32 mRNA in 
the CNS originates from oligodendrocytes, which is consistent 
with the in situ hybridization localization of Cx32 mRNA in 
adult rat CNS (Micevych and Abelson, 1991). To further sub- 
stantiate this idea, we analyzed Cx32 mRNA expression in my- 
elin-dejicient rats and jimpy mice, which have mutations in the 
PLP gene, and drastically reduced levels of all myelin-related 
mRNAs (Hudson, 1990). Northern blot analysis of affected male 
myelin-dejcient rats and their age-matched normal male litter- 
mates revealed that affected males had much lower levels of 
Cx32 mRNA at every age (Fig. 12). The levels of Cx32 mRNA 
in the brains of jimpy mice were also much lower than those in 
the brains of age-matched normal mice as well as shiverer mice, 
which have a recessively inherited mutation in the MBP gene 
(Hudson, 1990). Reprobing the blots for PLP mRNA demon- 
strated that the levels of PLP mRNA were much lower at every 
age in both myelin-de$cient rats and jimpy mice than in non- 
mutant animals and shiverer mice (Fig. 12). The changes in 
myelin-related mRNA expression in the mutant animals were 
not confined to Cx32 and PLP, as MBP and MAG are similarly 
affected (data not shown; see also Roth et al., 1985; Gardinier 
and Macklin, 1988; Kumar et al., 1988; Kumar et al., 1990; 
Macklin et al., 1991). Thus, the parallel reduction in Cx32 
mRNA and other myelin-related mRNAs in these PLP mutants 
provides strong evidence that most Cx32 mRNA in the CNS is 
derived from oligodendrocytes. 
Discussion 
The finding that mutations in Cx32 cause CMTX (Bergoffen et 
al., 1993) led us to investigate the role of Cx32 in myelinating 
glia. In this article, we have shown that Cx32 is expressed in 
myelinating Schwann cells and oligodendrocytes, but is local- 
ized to different parts of each cell. In the PNS, Cx32 is found 
mainly in the incisures and paranodal regions of myelinating 
Schwann cells, whereas in the CNS, it is found in oligodendro- 
cyte cell bodies and processes. In both Schwann cells and oli- 
godendrocytes, Cx32 protein and mRNA are expressed in a co- 
ordinate manner with those of other myelin genes. In Schwann 
cells, the expression of Cx32 mRNA and protein is develop- 
mentally regulated and depends on the integrity of axon- 
Schwann cell interactions. In oligodendrocytes, Cx32 is ex- 
pressed in concert with other myelin genes, both in normal de- 
velopment and in jimpy mice and myelin-dejicient rats. Thus, 
Cx32 is expressed as part of the myelinating phenotype of both 
Schwann cells and oligodendrocytes. 
The Journal of Neuroscience, December 1995, 75(12) 8289 
Figure 9. Immunohistochemical analysis of Cx32 in the ventral funiculus of adult rat spinal cord. These are photomicrographs of transverse (A,B) 
and longitudinal sections (C,D), double-labeled with a rabbit antiserum against Cx32 (A,C) and a mouse monoclonal antibody against MOG (B,D), 
and visualized with rhodamine-/and fluorescein-coupled secondary antibodies, respectively. Cx32-immunoreactivity is found in oligodendrocytes 
(0) and their processes, some of which are indicated by UTYOWS. MOG-immunoreactivity is found on the external/abaxonal surface of the myelin 
sheath, around a few oligodendrocyte processes (arrowheads), but not in the oligodendrocytes themselves (0). Some myelinated axons are indicated 
(a in A and B and 1,2,3 in C and D); the myelin sheath is unlabeled by Cx32 or MOG. Scale bar, 10 pm. 
Gap junctions in Schwann cells 
Since Cx32 forms gap junctions in many tissues, its localization 
in the incisures and paranodal regions indicates that gap junc- 
tions should be found at these locations. Small collections of 
hexagonally packed particles of the appropriate size to be gap 
junctions have been found in the incisures and paranodes of the 
PNS myelin sheath by freeze-fracture electron microscopy (San- 
dri et al., 1982). As these collections of particles seen by freeze- 
fracture are characteristic of gap junctions, and Cx32 is found 
at these same sites, it is reasonable to propose that these gap 
junctions contain Cx32. Since they link apposed layers of the 
same cell, these could be called “reflexive” gap junctions, 
which have also been described in the kidney and other tissues 
(Majack and Larsen, 1980). Why typical gap junctions have not 
been noted in incisures and paranodes is unclear, as these struc- 
tures have been extensively studied by transmission electron mi- 
croscopy (Thomas and Ochoa, 1984; Peters et al., 1991). 
More typical gap junctions, between different Schwann cells, 
have also been described. Electrophysiological recordings and 
tracer studies have revealed gap junctions between nonmyeli- 
nating Schwann cells (but not between myelinating Schwann 
cells) in peripheral nerve (Konishi, 1990). In peripheral nerve 
undergoing Wallerian degeneration, gap junctions between ad- 
jacent Schwann cells have been observed by transmission elec- 
tron microscopy (Tetzlaff, 1982), and there existence has also 
been inferred by recent electrophysiological observations (Bru- 
net and Jirounek, 1994). Finally, gap junctions have been ob- 
served between rat Schwann cells cultured in the absence of 
forskolin (Chanson et al., 1993). The connexin(s) that forms gap 
junctions between nonmyelinating, denervated, and cultured rat 
Schwann cells has not been identified. Since Cx32 appears to 
be expressed by nonmyelinating Schwann, it may form the gap 
junctions in these cells. The connexin expressed by Schwann 
cells cultured in the absence of forskolin is unlikely to be Cx32, 
which we find to be expressed at very low levels under these 
conditions, and which has different electrophysiological prop- 
erties than those described by Chanson et al. (1993). 
How do CMTX mutations cause neuropathy? 
Many different mutations in the Cx32 gene cause CMTX. To 
date, 33 different mutations, affecting nearly every portion of 
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Figure 10. Western blot analysis of Cx32 in the CNS. Each lane contains 25 (*g of protein homogenate (Ho) from developing rat spinal cord or 
brainstem at the indicated ages, or from a myelin preparation (My) of adult rat spinal cord or brainstem. The blots were hybridized with a rabbit 
antiserum against rat Cx32, then rehybridized with a rabbit antiserum against rat PLP The blots of developing spinal cord and brainstem were 
hybridized together and exposed to film for 5 min (Cx32) and 1 min (PLP). The blots of spinal cord and brainstem myelin were hybridized together 
and exposed to film for 3 min (Cx32) and 10 set (PLP). The arrowheads indicate the position of PLP and its alternatively spliced isoform, DM20. 
the Cx32 protein, have been found in 39 kindreds (Bone et al., 
1995). To determine whether these mutations result in a loss of 
function, Bruzzone et al. (1994) expressed three different CMTX 
genes, as well as the wild-type Cx32 gene, in Xenopus oocytes. 
Whereas the wild-type Cx32 formed gap junctions, no oocytes 
expressing any of the three CMTX cDNAs formed functional 
gap junctions with oocytes expressing Cx26 or wild-type Cx32. 
Using a similar approach, Rabadan-Diehl and colleagues (1994) 
found that another CMTX mutation (Arg 200 + stop codon) 
did not destroy channel activity, indicating that CMTX muta- 
tions may disrupt gap junctions in other ways besides a simple 
Brainstem 
loss of function. To determine whether Cx32 mutations could 
also have a dominant-negative effect, Bruzzone et al. (1994) 
coinjected the same three CMTX mutations described above 
with wild-type Cx26, which is often coexpressed with Cx32 
(Nicholson et al., 1987; Meda et al., 1993; Zhang and Nicholson, 
1994). Oocytes that were coinjected with wild-type Cx26 and 
wild-type Cx32 cDNAs formed gap junctions when apposed to 
oocytes that expressed wild-type Cx26 cDNA (Barrio et al., 
1991). Oocytes that were coinjected with wild-type Cx26 and 
the CMTX mutations, however, showed decreased junctional 




Figure II. Northern blot analysis of Cx32 mRNA in developing brain. Each lane contains an equal amount (10 p,g) of total RNA isolated from 
the cerebrum, cerebellum, and brainstem. The blots were successively hybridized with a radiolabeled cDNA probe for Cx32 (A), PLP (B), and 
GAPDH (C), and exposed to film for 15 d (Cx32), 2 hr (PLP), and 16 hr (GAPDH), respectively. 




Figure 12. Northern blot analysis of Cx32 mRNA expression in the brains of myelin mutants. Each lane contains an equal amount (10 pg) of 
total RNA isolated from the whole brains (cerebrum, cerebellum, and brainstem) of individual animals of the indicated ages-myelin-dejicient rats 
and their normal littermates, shiverer mice, and jimpy mice. RNA from cerebra of normal mice is shown for comparison. The blots were successively 
hybridized together with a radiolabeled cDNA probe for Cx32 (A), PLP (B), and GAPDH (C), and exposed to film for 14 d (Cx32), 1 d (PLP), 
and 16 hr (GAPDH), respectively. Note that in rats, the major PLP transcripts in rats are 3.2 and 1.6 kb; in mice, 3.2 and 2.8 kb are main transcripts. 
many CMTX mutations cause a loss of functional Cx32 protein, 
and that at least some CMTX mutations can also have a domi- 
nant-negative effect. Yet, in spite of the large number of differ- 
ent mutations, and the evidence that different mutations may 
have different functional effects, there is no compelling evidence 
that different mutations cause different clinical phenotypes. 
The localization of Cx32 in the Schwann cell myelin sheath, 
and the loss of function of CMTX mutations in oocytes, strongly 
suggest hat at least some CMTX mutations cause a loss of func- 
tional gap junctions in the incisures and paranodes. Why these 
gap junctions are critical to the normal health of myelinated 
axons, however, remains to be determined. One potentially im- 
portant consideration is that the geometry of the myelin sheath 
itself. Myelin is a fundamental adaptation of jawed vertebrates, 
and is formed by the enormous expansion of Schwann cell and 
oligodendrocyte membrane (Peters et al., 1991). Gap junctions 
in the paranodes and incisures would allow ions and small mol- 
ecules to diffuse radially, directly tranversing the myelin sheath, 
instead of circumferentially through the Schwann cell cytoplasm, 
which would be a much longer pathway. In the largest myelin 
sheaths of mammals, this potential radial pathway would be 
more than lOOO-fold shorter than the circumferential pathway, 
as the unrolled myelin sheath is more than 4 mm long, whereas 
the compact myelin sheath is less than 4 pm thick (Friede and 
Bischhausen, 1980). If CMTX mutations interrupt the function 
of these gap junctions, then this radial pathway would be abol- 
ished. At this time, we can only speculate as to what are the 
crucial molecules that pass through these gap junctions, or even 
whether the interruption of diffusion towards or away from the 
axon is more important. 
A related issue is why mutations of Cx32 selectively affect 
myelinating Schwann cells. Patients who have CMTX have not 
been reported to have significant abnormalities in other tissues 
that express Cx32. The level of Cx32 expression does not seem 
to be critical, as several tissues, such as the brain and spleen, 
express levels of Cx32 mRNA that are comparable to peripheral 
nerve, and liver expresses much higher levels (Nishi et al., 1991; 
Bergoffen et al., 1993; Meda et al., 1993). Myelinating Schwann 
cells may be uniquely susceptible to Cx32 mutations because 
Cx32 is the only connexin they express. In support of this idea, 
we have not detected Cx43, Cx40, or Cx26 mRNA in rat 
Schwann cells treated with forskolin (Fig. 8 and data not 
shown). Cultured sciatic fibroblasts express Cx43 mRNA (Fig. 
8), and adult sciatic nerve expresses a low level of Cx43 mRNA 
that is not modulated by axotomy (data not shown), indicating 
Cx43 mRNA in nerve is derived from fibroblasts and not mye- 
linating Schwann cells. On the other hand, there is a growing 
body of evidence that most cell types express more than one 
connexin. The liver, for example, expresses Cx32 and Cx26 
(Nicholson et al., 1987; Meda et al., 1993; Kuraoka et al., 1993), 
and epidermal cells express four different connexins (Goliger 
and Paul, 1994). 
Cx32 in CNS myelin 
Patients who have CMTX are not known to have CNS abnor- 
malities, although oligodendrocytes, the only other myelin-form- 
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ing cells, have been reported to express Cx32 mRNA and protein 
(Dermietzel et al., 1989; Micevych and Abelson, 1991). In 
agreement with previous reports (Naus et al., 1990; Belliveau et 
al., 1991), we found regional and developmental differences in 
the expression of Cx32 mRNA. We extended these observations 
by demonstrating a close association between Cx32 mRNA ex- 
pression and that of other myelin genes, both in normal devel- 
opment and in PLP mutants. Western blot analysis of Cx32 also 
demonstrated regional and developmental differences, as well as 
decreased expression in PLP mutants. Cx32 protein was more 
abundant in the pons and spinal cord than in the cerebrum and 
cerebellum, and the amount of protein accumulated in parallel 
with PLP These results differ from those of Belliveau et al. 
(1991) who did not find a developmental increase in Cx32 pro- 
tein in the cerebrum or hindbrain. The good agreement between 
the levels of Cx32 mRNA and protein both in development and 
in PLP mutants, nevertheless, indicates that most of the Cx32 
mRNA and protein in the CNS is derived from oligodendro- 
cytes. 
The localization of Cx32 in oligodendrocytes has received 
relatively little attention. Several workers have examined the lo- 
calization of Cx32 in the neurons of the spinal cord without 
mentioning oligodendrocyte labeling (Carr et al., 1991; Yama- 
moto et al., 1991). Dermietzel et al. (1989) reported Cx32-im- 
munoreactivity in the perinuclear region of oligodendrocytes, 
but did not systemically evaluate the localization of Cx32 during 
development. We found that in older animals, Cx32 is predom- 
inately found in cell bodies and processes, and was not found 
in compact myelin, in contrast to the recent report of Spray and 
Dermietzel (1995). These observations generally agree with the 
localization of gap junctions in by freeze-fracture electron mi- 
croscopy (Massa and Mugnaini, 1982; Sandri et al., 1982; Rob- 
inson et al., 1993). Whether Cx32 is also found in the paranodal 
regions of CNS myelin sheaths, which contains gap junctions 
by freeze-fracture, remains to be determined. 
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